Skip to main content

Advertisement

Log in

Expression of cyclins, p53, and Ki-67 in cervical squamous cell carcinomas: overexpression of cyclin A is a poor prognostic factor in stage Ib and II disease

  • Original Article
  • Published:
Virchows Archiv Aims and scope Submit manuscript

Abstract

We previously reported the overexpression of cyclins in uterine cervical carcinoma; however, their clinicopathological significance remained undetermined. In the present study, we examined the immunohistochemical expression of cyclins (D1, E, A, B1), p53 and Ki-67 in squamous cell carcinoma (stage Ib+II; 80 cases, stage III+IV; 23 cases). Correlations between the expression of cyclins and clinicopathological parameters and patient survival were statistically evaluated. The results indicated that in the normal squamous epithelium, the expression of cyclins and Ki-67 was sporadically observed in the parabasal layer. Of the 103 cervical carcinomas, overexpression of cyclins D1, E, A, B1 and p53 was observed in 13 (13%), 23 (22%), 25 (24%), 18 (18%) and 23 (22%) cases, respectively, with a slight predominance in advanced stage tumors. The expression of cyclin D1, E, A and p53 significantly correlated with that of Ki-67 (Spearman’s rank correlation). Univariate and multivariate analyses revealed that lymph node metastasis and cyclin A overexpression were independent prognostic factors for unfavorable outcomes in stage Ib+II patients. These findings suggest that the overexpression of various cyclins is involved in the acquisition of the vigorous growth potential of cervical carcinoma cells, and that cyclin A is an independent prognosticator of cervical carcinoma in early stages.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Akasofu M, Oda Y (1995) Immunohistochemical detection of p53 in cervical epithelial lesions with or without infection of human papillomavirus types 16 and 18. Virchows Arch 425:593–602

    Article  CAS  PubMed  Google Scholar 

  2. Bae DS, Cho SB, Kim YJ, Whang JD, Song SY, Park CS, Kim DS, Lee JH (2001) Aberrant expression of cyclin D1 is associated with poor prognosis in early stage cervical cancer of the uterus. Gynecol Oncol 81:341–347

    Article  CAS  PubMed  Google Scholar 

  3. Barnes DM (1997) Cyclin D1 in mammary carcinoma. J Pathol 181:267–269

    Article  CAS  PubMed  Google Scholar 

  4. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV (1995) Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group. J Natl Cancer Inst 87:796–802

    CAS  PubMed  Google Scholar 

  5. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV (2002) The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55:244–265

    CAS  PubMed  Google Scholar 

  6. Brown DC, Cole D, Gatter KC, Mason DY (1988) Carcinoma of the cervix uteri: an assessment of tumour proliferation using the monoclonal antibody Ki67. Br J Cancer 57:178–181

    CAS  PubMed  Google Scholar 

  7. Burger RA, Monk BJ, Kurosaki T, Anton-Culver H, Vasilev SA, Berman ML, Wilczynski SP (1996) Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer. J Natl Cancer Inst 88:1361–1368

    CAS  PubMed  Google Scholar 

  8. Cattani P, Hohaus S, Bellacosa A, Genuardi M, Cavallo S, Rovella V, Almadori G, Cadoni G, Galli J, Maurizi M, Fadda G, Neri G (1998) Association between cyclin D1 (CCND1) gene amplification and human papillomavirus infection in human laryngeal squamous cell carcinoma. Clin Cancer Res 4:2585–2589

    CAS  PubMed  Google Scholar 

  9. Chen HY, Hsu CT, Lin WC, Tsai HD, Chang WC (2000) Prognostic value of p53 expression in stage IB1 cervical carcinoma. Gynecol Obstet Invest 49:266–271

    Article  CAS  PubMed  Google Scholar 

  10. Cheng WF, Chen CA, Lee CN, Wei LH, Hsieh FJ, Hsieh CY (2000) Vascular endothelial growth factor and prognosis of cervical carcinoma. Obstet Gynecol 6:721–726

    Article  Google Scholar 

  11. Cho NH, Kim YB, Park TK, Kim GE, Park K, Song KJ (2003) P63 and EGFR as prognostic predictors in stage IIB radiation-treated cervical squamous cell carcinoma. Gynecol Oncol 91:346–353

    Article  CAS  PubMed  Google Scholar 

  12. Dictor M, Ehinger M, Mertens F, Akervall J, Wennerberg J (1999) Abnormal cell cycle regulation in malignancy. Am J Clin Pathol 112:S40–S52

    CAS  PubMed  Google Scholar 

  13. Dong Y, Sui L, Tai Y, Sugimoto K, Hirao T, Tokuda M (2000) Prognostic significance of cyclin E overexpression in laryngeal squamous cell carcinomas. Clin Cancer Res 6:4253–4258

    CAS  PubMed  Google Scholar 

  14. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki67. J Immunol 133:1710–1715

    CAS  PubMed  Google Scholar 

  15. Gong J, Ardelt B, Traganos F, Darzynkiewicz Z (1994) Unscheduled expression of cyclin B1 and cyclin E in several leukemic and solid tumor cell lines. Cancer Res 54:4285–4288

    CAS  PubMed  Google Scholar 

  16. Guadagno TM, Ohtsubo M, Roberts JM, Assoian RK (1993) A link between cyclin A expression and adhesion-dependent cell cycle progression. Science 262:1572–1575

    CAS  PubMed  Google Scholar 

  17. Ho DM, Hsu CY, Chiang H (2000) MIB-1 labeling index as a prognostic indicator for survival in patients with FIGO stage IB squamous cell carcinoma of the cervix. Gynecol Oncol 76:97–102

    Article  CAS  PubMed  Google Scholar 

  18. Hsieh JK, Yap D, O’Connor DJ, Fogal V, Fallis L, Chan F, Zhong S, Lu X (2002) Novel function of the cyclin A binding site of E2F in regulating p53-induced apoptosis in response to DNA damage. Mol Cell Biol 22:78–93

    Article  CAS  PubMed  Google Scholar 

  19. Hui AM, Li X, Shi YZ, Takayama T, Torzilli G, Makuuchi M (2000) Cyclin D1 overexpression is a critical event in gallbladder carcinogenesis and independently predicts decreased survival for patients with gallbladder carcinoma. Clin Cancer Res 6:4272–4277

    CAS  PubMed  Google Scholar 

  20. Hunt CR, Hale RJ, Buckley CH, Hunt J (1996) p53 expression in carcinoma of the cervix. J Clin Pathol 49:971–974

    CAS  PubMed  Google Scholar 

  21. Isacson C, Kessis TD, Hedrick L, Cho KR (1996) Both cell proliferation and apoptosis increase with lesion grade in cervical neoplasia but do not correlate with human papillomavirus type. Cancer Res 56:669–674

    CAS  PubMed  Google Scholar 

  22. Kanai M, Shiozawa T, Xin L, Nikaido T, Fujii S (1998) Immunohistochemical detection of sex steroid receptors, cyclins, and cyclin-dependent kinases in the normal and neoplastic squamous epithelia of the uterine cervix. Cancer 82:1709–1719

    Article  CAS  PubMed  Google Scholar 

  23. Krivak TC, McBroom JW, Elkas JC (2002) Cervical and vaginal cancer. In: Berek JS (ed) Novak’s gynecology, 13th edn. Lippincott Williams & Wilkins, Philadelphia, pp 1199–1211

    Google Scholar 

  24. Krtolica A, Ludlow JW (1996) Hypoxia arrests ovarian carcinoma cell cycle progression, but invasion is unaffected. Cancer Res 56:1168–1173

    CAS  PubMed  Google Scholar 

  25. Krtolica A, Krucher NA, Ludlow JW (1999) Molecular analysis of selected cell cycle regulatory proteins during aerobic and hypoxic maintenance of human ovarian carcinoma cells. Br J Cancer 80:1875–1883

    Article  CAS  PubMed  Google Scholar 

  26. Michalides R, van Veelen N, Hart A, Loftus B, Wientjens E, Balm A (1995) Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res 55:975–978

    CAS  PubMed  Google Scholar 

  27. Michalides R, van Tinteren H, Balkenende A, Vermorken JB, Benraadt J, Huldij J, van Diest P (2002) Cyclin A is a prognostic indicator in early stage breast cancer with and without tamoxifen treatment. Br J Cancer 86:402–408

    Article  CAS  PubMed  Google Scholar 

  28. Nozoe T, Korenaga D, Futatsugi M, Saeki H, Ohga T, Sugimachi K (2002) Cyclin A expression in superficial squamous cell carcinoma of the esophagus and coexisting infiltrated lymphocyte follicle. Cancer Lett 188:221–229

    Article  CAS  PubMed  Google Scholar 

  29. Oka K, Arai T (1996) MIB1 growth fraction is not related to prognosis in cervical squamous cell carcinoma treated with radiotherapy. Int J Gynecol Pathol 15:23–27

    CAS  PubMed  Google Scholar 

  30. Porter PL, Malone KE, Heagerty PJ, Alexander GM, Gatti LA, Firpo EJ, Daling JR, Roberts JM (1997) Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med 3:222–225

    Article  CAS  PubMed  Google Scholar 

  31. Sherr CJ (1993) Mammalian G1 cyclins. Cell 73:1059–1065

    Article  CAS  PubMed  Google Scholar 

  32. Sherr CJ (1994) G1 phase progression: cyclin on cue. Cell 79:551–555

    Article  CAS  PubMed  Google Scholar 

  33. Shih HC, Shiozawa T, Kato K, Imai T, Miyamoto T, Uchikawa J, Nikaido T, Konishi I (2003) Immunohistochemical expression of cyclins, cyclin-dependent kinases, tumor-suppressor gene products, Ki-67, and sex steroid receptors in endometrial carcinoma: positive staining for cyclin A as a poor prognostic indicator. Hum Pathol 34:471–478

    Article  CAS  PubMed  Google Scholar 

  34. Shioazawa T, Li SF, Nakayama K, Nikaido T, Fujii S (1996) Relationship between the expression of cyclins/cyclin-dependent kinases and sex steroid receptors/Ki67 in normal human endometrial glands and stroma during the menstrual cycle. Mol Hum Reprod 2:745–752

    PubMed  Google Scholar 

  35. Skomedal H, Kristensen GB, Lie AK, Holm R (1999) Aberrant expression of the cell cycle associated proteins TP53, MDM2, p21, p27, cdk4, cyclin D1, RB, and EGFR in cervical carcinomas. Gynecol Oncol 73:223–228

    Article  CAS  PubMed  Google Scholar 

  36. Southern SA, Herrington CS (1998) Differential cell cycle regulation by low- and high-risk human papillomaviruses in low-grade squamous intraepithelial lesions of the cervix. Cancer Res 58:2941–2945

    CAS  PubMed  Google Scholar 

  37. Takeno S, Noguchi T, Kikuchi R, Uchida Y, Yokoyama S, Muller W (2002) Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma. Cancer 94:2874–881

    Article  CAS  PubMed  Google Scholar 

  38. Takeuchi H, Ozawa S, Ando N, Shih CH, Koyanagi K, Ueda M, Kitajima M (1997) Altered p16/MTS1/CDKN2 and cyclin D1/PRAD-1 gene expression is associated with the prognosis of squamous cell carcinoma of the esophagus. Clin Cancer Res 3:2229–2236

    CAS  PubMed  Google Scholar 

  39. Van de Putte G, Kristensen GB, Lie AK, Baekelandt M, Holm R (2004) Cyclins and proliferation markers in early squamous cervical carcinoma. Gynecol Oncol 92:40–46

    Article  PubMed  Google Scholar 

  40. Volm M, Koomagi R, Mattern J, Stammler G (1997) Cyclin A is associated with an unfavourable outcome in patients with non-small-cell lung carcinomas. Br J Cancer 75:1774–1778

    CAS  PubMed  Google Scholar 

  41. Wright TC, Ferenczy A, Kurman RJ (2002) Carcinoma and other tumors of the cervix. In: Kurman RJ (ed) Blaustein’s pathology of the female genital tract, 5th edn. Springer, Berlin Heidelberg New York, pp 325–346

    Google Scholar 

  42. Yasmeen A, Berdel WE, Serve H, Muller-Tidow C (2003) E- and A-type cyclins as markers for cancer diagnosis and prognosis. Expert Rev Mol Diagn 3:617–633

    Article  CAS  PubMed  Google Scholar 

  43. Zerfass K, Schulze A, Spitkovsky D, Friedman V, Henglein B, Jansen-Durr P (1995) Sequential activation of cyclin E and cyclin A gene expression by human papillomavirus type 16 E7 through sequences necessary for transformation. J Virol 69:6389–6399

    CAS  PubMed  Google Scholar 

  44. Zhai YL, Nikaido T, Shiozawa T, Orii A, Fujii S (1999) Expression of cyclins and cyclin-dependent kinases in smooth muscle tumors of the uterus. Int J Cancer 84:244–250

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported in part by a Grant-in-aid for Scientific Research from the Ministry of Education, Science, Sports and Culture (No. 12671583 and No.14370527), Japan.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tanri Shiozawa.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shiohara, S., Shiozawa, T., Miyamoto, T. et al. Expression of cyclins, p53, and Ki-67 in cervical squamous cell carcinomas: overexpression of cyclin A is a poor prognostic factor in stage Ib and II disease. Virchows Arch 446, 626–633 (2005). https://doi.org/10.1007/s00428-005-1252-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00428-005-1252-0

Keywords

Navigation